JPS581916B2 - Carrier for immobilizing physiologically active substances - Google Patents
Carrier for immobilizing physiologically active substancesInfo
- Publication number
- JPS581916B2 JPS581916B2 JP11753875A JP11753875A JPS581916B2 JP S581916 B2 JPS581916 B2 JP S581916B2 JP 11753875 A JP11753875 A JP 11753875A JP 11753875 A JP11753875 A JP 11753875A JP S581916 B2 JPS581916 B2 JP S581916B2
- Authority
- JP
- Japan
- Prior art keywords
- resin
- physiologically active
- carrier
- immobilizing
- cyanuric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q9/00—Arrangements in telecontrol or telemetry systems for selectively calling a substation from a main station, in which substation desired apparatus is selected for applying a control signal thereto or for obtaining measured values therefrom
- H04Q9/14—Calling by using pulses
Landscapes
- Engineering & Computer Science (AREA)
- Computer Networks & Wireless Communication (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
【発明の詳細な説明】
本発明は一般式(1)
(但しRは支持体を表わし、Xはハロゲン原子を表わす
)
で表わされる新しいジハロトリアジニル化された樹脂か
らなる生理活性物質固定化用担体に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a bioactive substance immobilization method comprising a new dihalotriazinylated resin represented by the general formula (1) (where R represents a support and X represents a halogen atom). This invention relates to a carrier for chemical conversion.
この生理活性物質固定化用担体はハロゲン化シアヌルと
、アミン基、置換アミノ基、イミノ基、水酸基もしくは
スルフヒドリル基を有する樹脂(以下R一樹脂と略す)
とを反応させて得られる。This carrier for immobilizing a physiologically active substance is a cyanuric halide and a resin having an amine group, a substituted amino group, an imino group, a hydroxyl group, or a sulfhydryl group (hereinafter abbreviated as R-resin).
Obtained by reacting with.
更にハロゲン化−S−シアヌルと、R−樹脂とを反応さ
せて得られる樹脂組成物と、緩衝液と接触させて実質的
に無機塩素を含有しない改良された活性発現を示す樹脂
組成物が得られる。Furthermore, a resin composition obtained by reacting a halogenated S-cyanuric acid with an R-resin and a resin composition that exhibits improved activity without substantially containing inorganic chlorine when brought into contact with a buffer solution is obtained. It will be done.
従来、生理活性物質固定化に用いられる担体としては、
吸着法による生理活性物質固定化用担体として、活性炭
、ベントナイト、アルミナ、などの無機物質、イオン交
換樹脂あるいはイオン交換セルロースなどのイオン交換
体などが広く用いられている。Conventionally, carriers used for immobilizing physiologically active substances include:
As carriers for immobilizing physiologically active substances by adsorption methods, inorganic substances such as activated carbon, bentonite, and alumina, and ion exchangers such as ion exchange resins and ion exchange cellulose are widely used.
また支持体を特定の化合物で化学修飾して、固定しよう
とする物質に対し特異的あるいは非特異的な親和性を附
与したものなどが知られている。Also known are those in which the support is chemically modified with a specific compound to impart specific or non-specific affinity to the substance to be immobilized.
これら担体を使用した生理ff3t9E物質の固定化で
は、多くの場合吸着量が少ない、吸着された生理活性物
質が吸着により失活することがある、吸着させた生理活
性物質が使用中容易に溶出される、非可逆的吸着の場合
があるなどの種々の欠点を有しており、アフイニテイク
ロマトグラフイーには応用できても生理活性物質固定化
用担体としては応用できなかった。When immobilizing physiological ff3t9E substances using these carriers, the adsorbed amount is often small, the adsorbed physiologically active substance may be deactivated due to adsorption, and the adsorbed physiologically active substance may be easily eluted during use. It has various drawbacks such as irreversible adsorption, and although it can be applied to affinity chromatography, it cannot be used as a carrier for immobilizing physiologically active substances.
本発明者らは先に生理活性物質の固定化用担体として活
性なハロゲンを有するS−トリアジン誘導体で修飾した
担体に関する発明をした(特開昭48−56770)。The present inventors previously made an invention regarding a carrier modified with an S-triazine derivative having an active halogen as a carrier for immobilizing a physiologically active substance (Japanese Patent Application Laid-Open No. 56770/1983).
更に本発明者らは活性なハロゲンを有しないS一トリア
ジン誘導体で修飾された一般式(If)などを示す。Furthermore, the present inventors show general formula (If) modified with an S-triazine derivative having no active halogen.
(但しR’ , R“はHまたは炭素数1−6のアルキ
ル基を、R“′はアミノ酸残基を示す)〕
で表わされるごとき生理活性物質固定化用担体がペプチ
ド、蛋白質、酵素などの生理活性物質に対し非特異的な
強い吸着能を有することを見出した。(However, R', R'' represent H or an alkyl group having 1 to 6 carbon atoms, and R'' represents an amino acid residue.) It was found that it has a strong non-specific adsorption ability for physiologically active substances.
また本発明者らはその担体が吸着力の点において従来の
担体および上記特開昭48−56770号発明で開示さ
れた活性なハロゲンを有するS一トリアジン誘導体で修
飾した支持体からなる担体にはみられなかった強さを示
し、さらに再生、反復使用が可能であるなどの利点を有
するので酵素の固定化などの目的に適用できるものであ
ることを見出し、昭和50年8月19日付で「生理活性
物質固定化用担体」の名称で特許出願を行った。In addition, the present inventors have found that the carrier is composed of a conventional carrier and a support modified with an S-triazine derivative having an active halogen disclosed in the invention of JP-A No. 48-56770 in terms of adsorption power. They discovered that it could be applied to purposes such as enzyme immobilization because it showed unprecedented strength and could be regenerated and used repeatedly, and on August 19, 1975, A patent application was filed under the name "Carrier for Immobilization of Physiologically Active Substances."
その後更に詳細な検討を行った結果トリアジン骨格にあ
る3個のハロゲンのうち、第1ハロゲンは樹脂と反応し
、活性な第2、第3のハロゲン原子は残存するが、この
残存する第2、第3の活性なハロゲン原子を有する一般
式(1)で表わされるジハロトリアジニル化された樹脂
組成物からなる生理活性物質固定化用担体が、驚くべき
ことに酵素蛋白などの結合能、附着結合された蛋白等の
安定性などの点で優れており、優れた固定化酵素を与え
ることを見出した。After that, a more detailed study revealed that among the three halogens in the triazine skeleton, the first halogen reacts with the resin, and the active second and third halogen atoms remain; Surprisingly, a carrier for immobilizing a physiologically active substance consisting of a dihalotriazinylated resin composition represented by the general formula (1) having a third active halogen atom has the ability to bind enzyme proteins, etc. It has been found that the adhesion-bonded proteins are excellent in terms of stability, etc., and provide excellent immobilized enzymes.
即ち、意外にも、トリアジン環に結合した生理活性物質
の活性発現を阻害すると考えられていた活性な第2、第
3ハロゲンが残存しても生理活性物質の活性発現を阻害
しないことを見出した。That is, it was surprisingly found that even if the active secondary and tertiary halogens, which were thought to inhibit the activity expression of the physiologically active substance bound to the triazine ring, remained, they did not inhibit the activity expression of the physiologically active substance. .
更にハロゲン化一S−シアヌルとR−樹脂とを反応させ
て得られる一般式(1)で表わされる樹脂組成物の性質
について詳しく検討を加えたところ、ハロゲン化シアヌ
ルとR一樹脂を反応させて得られる樹脂組成物には充分
なる量の脱イオン水で洗浄して洗液より硝酸銀でハロゲ
ンを検出しないことを確めた後でも無機ハロゲンが残存
していること、およびこの無機ハロゲンが生理活性物質
を固定化しても、その活性の発現に大きな影響を与える
こと、即ち酬酸性の強い酸性ラクターゼなどでは活性の
低下は余りないが、酵素によっては活性の低下がみられ
ることを見出した。Furthermore, we conducted a detailed study on the properties of the resin composition represented by the general formula (1) obtained by reacting the S-cyanuric halide with the R-resin. Even after washing the resulting resin composition with a sufficient amount of deionized water and confirming that no halogen was detected using silver nitrate from the washing solution, it was found that inorganic halogen remained and that this inorganic halogen was physiologically active. We have found that even when a substance is immobilized, it has a significant effect on the expression of its activity; in other words, although the activity of strongly acidic acid lactase and the like does not decrease much, the activity of some enzymes does decrease.
即ちその結果その残存する無機ハロゲンの除去法につい
て検討を加えて、ハロゲン化シアヌルとR一樹脂とを反
応させて得られる樹脂組成物を緩衝液と接触させること
によって実質的に無機ハロゲンを含有しない樹脂組成物
を製造する方法を見出し本願を完成するに至ったもので
ある。That is, as a result, we investigated a method for removing the remaining inorganic halogen, and by bringing the resin composition obtained by reacting the cyanuric halide and the R-resin into contact with a buffer solution, we obtained a method that substantially does not contain inorganic halogen. The present invention was completed by discovering a method for producing a resin composition.
このようにして得られた樹脂組成物は、緩衝液との処理
を行わない樹脂組成物に比し、生理活性物質、例えば酵
素等の活性の発現において改善された性質を示す。The resin composition thus obtained exhibits improved properties in terms of expression of the activity of physiologically active substances, such as enzymes, as compared to resin compositions that are not treated with a buffer solution.
次に本願発明の具体的な説明をするならば、ジハロトリ
アジニル樹脂の製法は比較的容易であるが、その工程は
(1)R一樹脂を予め塩酸溶液,苛性ソーダ溶液で交互
に洗浄し、OH型とした後、(2)H20で十分膨潤さ
せた状態のR一樹脂に、(3)有機溶媒に浴かしたハロ
ゲン化シアヌルを反応させる過程から成り立つ。Next, to give a specific explanation of the present invention, the method for producing dihalotriazinyl resin is relatively easy, but the steps are (1) R-resin is washed alternately with a hydrochloric acid solution and a caustic soda solution in advance. After converting into an OH type, the process consists of (2) reacting the R1 resin sufficiently swollen with H20 with (3) cyanuric halide soaked in an organic solvent.
(3)の反応は有機溶媒と水の混合溶液にR一樹脂を浸
漬し、有機溶媒に溶解したハロゲン化シアヌルを加えて
攪拌することにより行う。The reaction (3) is carried out by immersing the R-resin in a mixed solution of an organic solvent and water, adding cyanuric halide dissolved in the organic solvent, and stirring.
(添加順序は逆でもよい。)反応後、塩酸、硫酸、酢酸
溶液などを加えて反応を完結させた後、反応した樹脂を
涙別し、有機溶媒で十分洗浄し、乾燥すれば目的のジハ
ロトリアジニル樹脂が得られる。(The order of addition may be reversed.) After the reaction, add hydrochloric acid, sulfuric acid, acetic acid solution, etc. to complete the reaction, separate the reacted resin, thoroughly wash it with an organic solvent, and dry it. A halotriazinyl resin is obtained.
本発明に用いられる樹脂はアミン基、置換アミノ基、イ
ミノ基、水酸基もしくはスルフヒドリル基を官能基とし
て有する樹脂ならば倒れでもよいが、具体的なものとし
ては、例えばアミン基、置換アミン基、イミノ基、水酸
基、スルフヒドリル基を官能基として有するポリスチレ
ン系、芳香族アミン系、フェノール系、アルキレンポリ
アミン系、脂肪族アミン系、メラミングアニジンとホル
マリンの重合体、アミノチアゾール系の樹脂などがあげ
られ、更に具体的には、デュオライトA2、デュオライ
トA7(いずれも商品名、ケミカルプロセス社)、ダイ
ヤイオン2OA、ダイヤイオンWA20、ダイヤイオン
WA21(いずれも商品名、三菱化成工業社)、アンバ
ーライトIR−45、アンバーライトIR−4B、アン
バーライトIRA−93(いずれも商品名、ローム・ア
ンドハース社)、イマツクA−17(商品名)、インダ
ストリーレミートシャツピー アクテイビトN.V.な
どが好ましく用いられる。The resin used in the present invention may be a resin having an amine group, a substituted amino group, an imino group, a hydroxyl group, or a sulfhydryl group as a functional group. Polystyrene-based, aromatic amine-based, phenol-based, alkylene polyamine-based, aliphatic amine-based, polymers of melaminous anidine and formalin, aminothiazole-based resins, etc. have polystyrene, hydroxyl, and sulfhydryl groups as functional groups. Specifically, Duolite A2, Duolite A7 (both trade names, Chemical Process Co., Ltd.), Diaion 2OA, Diaion WA20, Diaion WA21 (all trade names, Mitsubishi Chemical Industries, Ltd.), Amberlight IR- 45, Amberlight IR-4B, Amberlight IRA-93 (all product names, Rohm & Haas), Imatsu A-17 (product name), Industry Remit Shirt Piece Activit N. V. etc. are preferably used.
ハロゲン化シアヌルとしては塩化シアヌル、臭化シアヌ
ル、弗化シアヌルが何れも使用可能である。As the cyanuric halide, cyanuric chloride, cyanuric bromide, and cyanuric fluoride can all be used.
ハロゲン化シアヌルを溶解するために用いられる有機溶
媒としては、アセトン、アセトニトリル、ジオキサン、
トルエンなどがあげられる。Organic solvents used to dissolve cyanuric halides include acetone, acetonitrile, dioxane,
Examples include toluene.
また反応完結後、反応した樹脂を戸別し、洗浄する際に
用いられる有機溶媒も前記と同じものが用いられる。Further, after the reaction is completed, the same organic solvent as mentioned above is used when the reacted resin is distributed and washed from house to house.
反応は通常、0゜〜100℃、好ましくは室温で行われ
るが、発熱をおさえるために冷却下に行ってもよい。The reaction is usually carried out at 0° to 100°C, preferably at room temperature, but may be carried out under cooling in order to suppress heat generation.
反応時間は通常、5分〜4時間以内で終了するが、大量
反応させるときには発熱によるトラブルをさけるため、
冷却し、また溶媒量を増して希釈したり、特に反応初期
において攪拌をコントロールすることが必要である。The reaction time is usually completed within 5 minutes to 4 hours, but in order to avoid troubles due to heat generation when performing a large-scale reaction,
It is necessary to cool the reaction mixture, dilute it by increasing the amount of solvent, and control stirring especially at the beginning of the reaction.
以上のようにして得られたジハロトリアジニル樹脂と、
緩衝液を接触させる方法は、前述のハロゲン化シアヌル
とR一樹脂との反応後、有機溶媒で洗浄したのち、緩衝
液と接触させ、そのまま乾燥しでもよいし、また再度、
水、有機溶媒で置換し乾燥してもよい。The dihalotriazinyl resin obtained as above,
The method of bringing the buffer into contact may be as follows: After the reaction of the cyanuric halide with the R-resin, washing with an organic solvent, contacting with the buffer and drying as is, or again.
It may be replaced with water or an organic solvent and then dried.
また緩衝液と接触せしめずに取得した樹脂祖成物を酵素
との反応に先立って緩衝孜と接触させてもよい。Alternatively, a resin precursor obtained without contacting with a buffer may be brought into contact with a buffer prior to reaction with an enzyme.
ここで洗浄及び置換用に用いられる有機溶媒もまた、塩
化シアヌルを溶解するのに用いられるものと同じものが
用いられる。The organic solvent used here for washing and substitution is also the same as that used to dissolve cyanuric chloride.
また樹脂とハロゲン化シアヌルとの反応後、接触に用い
られる緩衝液は、リン酸や酢酸ソーダを含むものが好ま
しく用いられ、例えば、I M −リン酸緩衝液(pH
7−8)、0、IN−酢酸ソーダ溶W(pH約8.8)
などが用いられる。Further, the buffer used for contact after the reaction between the resin and the cyanuric halide preferably contains phosphoric acid or sodium acetate. For example, IM-phosphate buffer (pH
7-8), 0, IN-Sodium acetate solution W (pH approx. 8.8)
etc. are used.
次に実施例によってジハロトリアジニル樹脂の製法を詳
しく述べる。Next, a method for producing a dihalotriazinyl resin will be described in detail with reference to Examples.
実施例 1
多孔性弱塩基性陰イオン交換樹脂デュオライトA−7(
OH型)(商品名)30gをIN HCl500mlで
処理後、水洗し、史にIN NaOH500mlで処理
し、その後、洗液が中性附近になるまで水洗する。Example 1 Porous weakly basic anion exchange resin Duolite A-7 (
OH type) (trade name) (30 g) was treated with 500 ml of IN HCl, washed with water, treated with 500 ml of IN NaOH, and then washed with water until the washing solution became near neutral.
アセトンー水の混合溶媒(容量比1:1)100mlを
加え、15分間攪拌した後、塩化シアヌル25gをアセ
トン300mlに溶解した溶液を加え、室温で5分間激
しく攪拌する。After adding 100 ml of a mixed solvent of acetone and water (volume ratio 1:1) and stirring for 15 minutes, a solution of 25 g of cyanuric chloride dissolved in 300 ml of acetone was added and stirred vigorously for 5 minutes at room temperature.
その後、20%酢酸水溶液200mlを加え、10分間
攪拌する。Then, 200 ml of 20% acetic acid aqueous solution was added and stirred for 10 minutes.
すばやく樹脂を涙別し、充分アセトンで洗浄する。Quickly separate the resin and wash thoroughly with acetone.
風乾後、無機塩素を除去するためにIM酢酸ソーダで充
分洗浄し、再度、水、アセトン置換し、五酸化リン上室
温で真空乾燥する。After air drying, it is thoroughly washed with IM sodium acetate to remove inorganic chlorine, replaced with water and acetone again, and vacuum dried over phosphorus pentoxide at room temperature.
(樹脂中のハロゲンの分別定量により、この樹脂中には
1. 1− m mo l e/g樹脂の塩化シアヌル
が反応していた。(By fractional and quantitative determination of halogen in the resin, 1.1-mmol/g of resin was found to have reacted with cyanuric chloride.
)実施例 2
また別法として、実施例1と同様に反応し、アセトン洗
浄後、直ちに五酸化リン上室温で真空乾燥し、次いで、
IN一酢酸ソーダで充分洗浄し、再度、水、アセトン置
換して五酸化リン上室温で真空乾燥する。) Example 2 Alternatively, the reaction was carried out in the same manner as in Example 1, and after washing with acetone, it was immediately vacuum dried over phosphorus pentoxide at room temperature, and then,
Wash thoroughly with IN sodium monoacetate, replace with water and acetone, and vacuum dry over phosphorus pentoxide at room temperature.
(同様に1. 1 m mo le/9樹脂の塩化シア
ヌルが反応していた。(Similarly, 1.1 mmole/9 resin of cyanuric chloride was reacted.
)実施例 3
多孔性弱塩基性陰イオン交換樹脂アンバーライトIRA
−93(Cl型)(商品名)100gを2NHCl50
0mlで処理後、水洗し、更に2NNaOH 5 0
0mlで処理し、その後、洗液が中性附近になるまで水
洗する。) Example 3 Porous weakly basic anion exchange resin Amberlite IRA
-93 (Cl type) (trade name) 100g with 2NHCl50
After treatment with 0ml, wash with water and further add 2N NaOH 50
0 ml, and then washed with water until the washing liquid becomes approximately neutral.
アセトニトリルー水の混合溶媒(容量比60:40)5
00mlを加え、15分間攪拌後、塩化シアヌル70g
をアセトニトリル1000mlに溶解した溶液を加え、
室温で10分間激しく攪拌する。Mixed solvent of acetonitrile and water (volume ratio 60:40) 5
After stirring for 15 minutes, add 70g of cyanuric chloride.
Add a solution of dissolved in 1000 ml of acetonitrile,
Stir vigorously for 10 minutes at room temperature.
その後、INHCtでpHを4に調整し、10分間攪拌
する。Then, adjust the pH to 4 with INHCt and stir for 10 minutes.
すばやく戸別し、充分アセトンで洗浄し、風乾後、無機
塩素を除去するためのIM−リン酸緩衝液(pH7−8
)で充分洗浄し、再度、水、アセトン置換をし、五酸化
リン上、室温で真空乾燥する。Quickly wash each door with acetone, air dry, and add IM-phosphate buffer (pH 7-8) to remove inorganic chlorine.
), then replace with water and acetone again, and vacuum dry over phosphorus pentoxide at room temperature.
(樹脂中のハロゲンの分別定量により、この樹脂中には
0. 5 m mo l e/g樹脂の塩化シアヌルが
反応していた。(By fractional and quantitative analysis of the halogen in the resin, 0.5 mmole/g of cyanuric chloride was found to have reacted with the resin.
)実施例 4
実施例1と同様に洗浄作成した多孔性弱塩基性陰イオン
交換樹脂ダイヤイオンWA−21(OH型(商品名)5
0gをジオキサンー水の混合溶媒(容量比30:70)
100ml中に懸濁し、臭化シアヌル40gをジオキサ
ン500wLlに溶解した溶液を加え、激しく攪拌下に
室温で反応さす。) Example 4 A porous weakly basic anion exchange resin Diaion WA-21 (OH type (trade name) 5) was prepared by washing in the same manner as in Example 1.
0g of dioxane-water mixed solvent (volume ratio 30:70)
A solution of 40 g of cyanuric bromide dissolved in 500 wL of dioxane was added to the suspension, and the mixture was reacted at room temperature with vigorous stirring.
その後、実施例1と同様の操作により、ジブロモトリア
ジニル化されたダイヤイオンWA−21を得た。Thereafter, dibromotoriazinylated Diaion WA-21 was obtained by the same operation as in Example 1.
(樹脂中のハロゲン定量により、この樹脂中には0.
4 8 m mo le/g樹脂の臭化シアヌルが反応
しでいた。(The halogen content in this resin was determined to be 0.
48 mmole/g of resin of cyanuric bromide had completely reacted.
)次に実施例1−3によって作成金れた樹脂を形いて行
った実験例を示す。) Next, an experimental example will be shown in which the resin prepared according to Examples 1-3 was molded.
実験例 I
L−リジン塩酸塩200mgを溶解した各pHの0.1
M緩衝液( pH 4〜6は酢酸、pH6〜8はリン酸
、p118〜10はホウ酸)40mlに実施例1で作成
した4,6−ジクロローs − トリアジニルーデュオ
ライトA75gを添加し,15時間5℃で緩やかに攪拌
した。Experimental Example I 0.1 of each pH in which 200 mg of L-lysine hydrochloride was dissolved
To 40 ml of M buffer (acetic acid for pH 4-6, phosphoric acid for pH 6-8, boric acid for pH 118-10) was added 75 g of 4,6-dichloros-triazinyl-duolite A prepared in Example 1, The mixture was gently stirred at 5° C. for 15 hours.
攪拌後沢過し、INNaOHでよく洗浄し、洗液に含ま
れるリジンの量を測定し、上記担体に結合したリジン量
を算出した。After stirring, the mixture was filtered and thoroughly washed with INNaOH, and the amount of lysine contained in the washing liquid was measured to calculate the amount of lysine bound to the carrier.
その結果を表1に示した。The results are shown in Table 1.
別にコントロールとしてデュオライトA7トリアジン誘
導体C特開昭48−56770号公報実施例2に記載の
方法で製造した)を用いて同様な処理を行い、その結果
も付記した。Separately, as a control, Duolite A7 triazine derivative C (produced by the method described in Example 2 of JP-A No. 48-56770) was subjected to the same treatment, and the results are also appended.
尚、実施例2で作成した4,6−ジクロローs −トリ
アジニルーデュオライトA7を用いても実施例1で作成
したものを用いたときと同様の結果が得られた。Incidentally, even when 4,6-dichloros-triazinylruduolite A7 prepared in Example 2 was used, the same results as when using the one prepared in Example 1 were obtained.
実験例 2
実験例1と同様な反応を30℃で行った結果を第2表に
示した。Experimental Example 2 Table 2 shows the results of a reaction similar to Experimental Example 1 conducted at 30°C.
実験例 3
牛血清アルブミン750mgを溶解した0. 1 M
リン酸緩衝液(pHs.o ) 2 0 0mlに実施
例1で作成した4,6−ジクロローs −トリアジニル
ーデュオライトA7 25gを添加し、15時間5℃
で緩やかに攪拌した後戸別し、5MNaClを含んだ0
.1Mリン酸緩衝液(pH8.0)でよく洗浄し不浴性
アルブミンを得た。Experimental Example 3 750 mg of bovine serum albumin was dissolved in 0.00 mg of bovine serum albumin. 1M
25 g of 4,6-dichloros-triazinylruduolite A7 prepared in Example 1 was added to 200 ml of phosphate buffer (pH s.o), and the mixture was incubated at 5°C for 15 hours.
After stirring gently with
.. It was thoroughly washed with 1M phosphate buffer (pH 8.0) to obtain non-bathable albumin.
このものはアルブミンを42mg/g樹脂含んでいた。This contained 42 mg albumin/g resin.
別に実施例1でコントロールとして用いたデュオライト
A7トリアジン誘導体および4,6−ジクロローs一ト
リアジニルーセルロース(英国特許1183258の実
施例1に記載の方法で製造した)について同様な処理を
行って得たアルブミンの固定化物はアルブミンをそれぞ
れ13mg/g樹脂および8,5mg/g樹脂含んでい
た。Separately, the Duolite A7 triazine derivative used as a control in Example 1 and 4,6-dichloros-triazinylcellulose (produced by the method described in Example 1 of British Patent No. 1183258) were treated in the same manner. The immobilized albumin contained 13 mg/g resin and 8.5 mg albumin/g resin, respectively.
実験例 4
麹菌アミノアシラーゼ(天野製薬社製)(比活性0.5
国際単位/mg蛋白)2.5.9を溶解した0.1M
リン酸緩衝液( pH8.0 ) 2 0 0mlに実
施例1で作成した4,6−ジクロローs−トリアジニル
ーデュオライトA7 25gを添加し、実験例3と同
様に処理してアミノアシラーゼの固定化物約25gを得
た。Experimental example 4 Aspergillus aminoacylase (manufactured by Amano Pharmaceutical Co., Ltd.) (specific activity 0.5
0.1M dissolved in International Units/mg protein) 2.5.9
25 g of 4,6-dichloro-s-triazinylruduolite A7 prepared in Example 1 was added to 200 ml of phosphate buffer (pH 8.0), and treated in the same manner as in Experimental Example 3 to fix aminoacylase. Approximately 25 g of compound was obtained.
この固定化物はアミノアシラーゼを32mg蛋白/g樹
脂含んでいた。This immobilization contained aminoacylase at 32 mg protein/g resin.
この固定化物10gを直径3cm、高さl.Ocmのカ
ラムに充填しカラムの温度を37℃に保ちN−アセチル
ーDL一メチオニンを0. 2 mol/lおよびC
o Cl2を0.2mmole/t含んだ0.05Mベ
ロナール緩衝液(pH8.0)をSV(空間速度)10
で通筒させた120時間後の通筒液中にはL−メチオニ
ンが75mg/ml含まれていた。10 g of this immobilized material was placed into a diameter of 3 cm and a height of 1. Packed into an Ocm column, the temperature of the column was maintained at 37°C, and 0.0% of N-acetyl-DL-methionine was added. 2 mol/l and C
o 0.05M veronal buffer (pH 8.0) containing 0.2 mmole/t of Cl2 at SV (space velocity) 10
After 120 hours of passing through the tube, the liquid contained 75 mg/ml of L-methionine.
一方実験例1でコントロールとして用いたデュオライト
A7トリアジン誘導体および実験例3でコントロールと
して用いた4,6−ジクロロ−s −トリアジニルーセ
ルロースを用いて同様な処理を行った場合アミノアシラ
ーゼ固定化物のアミノアシラーゼは11.1mg蛋白/
g樹脂および2.1mg蛋白/g樹脂であり、また通筒
液中のL−メチオニンはそれぞれ1.2mg/mlおよ
び0.1mg/ml含まれていた。On the other hand, when the same treatment was carried out using the Duolite A7 triazine derivative used as a control in Experimental Example 1 and the 4,6-dichloro-s-triazinyl-cellulose used as a control in Experimental Example 3, the aminoacylase immobilized Aminoacylase is 11.1mg protein/
g resin and 2.1 mg protein/g resin, and the L-methionine in the tube fluid was 1.2 mg/ml and 0.1 mg/ml, respectively.
実験例 5
酵母ラクターゼ(比活性119国際単位/mg蛋白)の
1.5gと2gのラクトースを溶解した0.1Mリン酸
緩衝液(pH8.0 )2 0 0mlに実施例1で作
成した4,6−ジクロローs−トリアジニルーデュオラ
イトA7 25gを添加し、15時間5℃で緩やかに
攪拌したのち戸別し、5MNaClと10mg/mlの
ラクトースを含んだ同じ緩衝液でよく洗浄し、不溶性ラ
クターゼを得た。Experimental Example 5 4, prepared in Example 1, was added to 200 ml of 0.1 M phosphate buffer (pH 8.0) in which 1.5 g of yeast lactase (specific activity 119 international units/mg protein) and 2 g of lactose were dissolved. 25 g of 6-dichloros-triazinyl duolite A7 was added, stirred gently at 5°C for 15 hours, and then washed separately with the same buffer containing 5 M NaCl and 10 mg/ml lactose to remove insoluble lactase. Obtained.
このラクターゼ固定化物10gを実験例4と同様なカラ
ムに充填し、5℃、sv10で市乳を通筒した。10 g of this lactase immobilized product was packed into a column similar to that in Experimental Example 4, and city milk was passed through the column at 5° C. and sv10.
20時間通筒後の市乳中のグルコース濃度は15.2m
g/mlであった。Glucose concentration in city milk after 20 hours in the bottle was 15.2 m
g/ml.
その後も連続して通筒し4日後のグルコース濃度もほと
んど変化しなかった。After that, the tube was continuously passed through the tube, and the glucose concentration after 4 days showed almost no change.
別に実験例1でコントロールとして用いたデュオライト
A7トリアジン誘導体を用いて同様な処理を行って得た
ラクターゼ固定化物の20時間通筒後の市乳中のグルコ
ース濃度は16.3mg/mlであったが、5日後の濃
度は3.5mg/mlに減少していた。Separately, the glucose concentration in city milk after 20 hours of incubation of the lactase immobilized product obtained by performing the same treatment using the Duolite A7 triazine derivative used as a control in Experimental Example 1 was 16.3 mg/ml. However, the concentration after 5 days had decreased to 3.5 mg/ml.
実験例 6
実施例1にもとづいて調製した4,6−ジクロローs−
トリアジニルーデュオライトA7(但し、リン酸緩衝液
による無機塩素除去を行なわなかったもので、リン酸緩
衝液のかわりに水で充分洗浄したもの。Experimental Example 6 4,6-dichloros- prepared based on Example 1
Triazinyl Duolite A7 (However, inorganic chlorine was not removed using a phosphate buffer, and the product was thoroughly washed with water instead of a phosphate buffer.)
洗浄液からもはや塩素イオンを硝酸銀で検出しなかった
。No more chloride ions were detected with silver nitrate in the cleaning solution.
)について実験例5と同一の実験を行った。), the same experiment as in Experimental Example 5 was conducted.
通筒液中のグルコースは2.5 mg/mlであったが
、5日後の濃度は殆んど含まれていなかった。Glucose in the tube fluid was 2.5 mg/ml, but the concentration after 5 days was almost negligible.
Claims (1)
) で表わされるジハロトリアジニル化された樹脂からなる
生理活性物質固定化用担体。 2 支持体とハロゲン化シアヌルとを反応させることを
特徴とする一般式(1) (但しRは支持体を表わし、Xはハロゲン原子を表わす
) で表わされる樹脂からなる生理活性物質固定化用担体の
製造法。[Claims] 1. A carrier for immobilizing a physiologically active substance comprising a dihalotriazinylated resin represented by the general formula (1) (where R represents a support and X represents a halogen atom). 2. A carrier for immobilizing a physiologically active substance made of a resin represented by the general formula (1) (where R represents a support and X represents a halogen atom), which is characterized by reacting a support with a cyanuric halide. manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11753875A JPS581916B2 (en) | 1975-09-29 | 1975-09-29 | Carrier for immobilizing physiologically active substances |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11753875A JPS581916B2 (en) | 1975-09-29 | 1975-09-29 | Carrier for immobilizing physiologically active substances |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5252983A JPS5252983A (en) | 1977-04-28 |
JPS581916B2 true JPS581916B2 (en) | 1983-01-13 |
Family
ID=14714264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11753875A Expired JPS581916B2 (en) | 1975-09-29 | 1975-09-29 | Carrier for immobilizing physiologically active substances |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS581916B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6033318U (en) * | 1983-08-12 | 1985-03-07 | 有限会社 伊坂光学研究所 | optical path extender |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4229537A (en) * | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
-
1975
- 1975-09-29 JP JP11753875A patent/JPS581916B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6033318U (en) * | 1983-08-12 | 1985-03-07 | 有限会社 伊坂光学研究所 | optical path extender |
Also Published As
Publication number | Publication date |
---|---|
JPS5252983A (en) | 1977-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2562571B2 (en) | Novel nitrilotriacetic acid derivatives and salts thereof, and methods for producing the same | |
US4229537A (en) | Preparation of trichloro-s-triazine activated supports for coupling ligands | |
US5092992A (en) | Polyethyleneimine matrixes for affinity chromatography | |
US4381239A (en) | Method for reducing the pyrogen content of or removing pyrogens from substances contaminated therewith | |
JPS61272202A (en) | Production of material for affinity chromatography | |
JPH0626667B2 (en) | Cyclodextrin adsorbent and its application | |
GB2092470A (en) | Method for reducing the pyrogen content of or removing pyrogens from solutions contaminated therewith | |
JPS615099A (en) | Thioether adsorbent for separating protein or like and manufacture | |
JPH01229965A (en) | Carrier for affinity chromatography with immobilized antibodies | |
JPS581916B2 (en) | Carrier for immobilizing physiologically active substances | |
US3847745A (en) | Preparation of water-insoluble biologically active materials | |
DE2102514A1 (en) | Process for the chemical coupling of biologically active substances to polymers containing oxirane | |
EP0403700B1 (en) | Polyethyleneimine matrixes for affinity chromatography | |
JPH0362389B2 (en) | ||
JPS5838152B2 (en) | Water-insoluble enzyme complex | |
JPH11152330A (en) | Polylysine, production of polylysine, polylysine composition, and production of medicine which removes endotoxin | |
US3723252A (en) | Method for removing pyrogenic substances out of urokinase | |
JPH0553802B2 (en) | ||
US4147592A (en) | Purification of urokinase | |
US3033758A (en) | Preparation of levans | |
JPS586536B2 (en) | Cellulose inion | |
JPH0359080B2 (en) | ||
JPS60237993A (en) | Method of immobilizing enzyme to hydroxyl group-containing fiber | |
JPH0336513B2 (en) | ||
JPS62155300A (en) | Production of immobilized physiologically active substance |